The FDA launched PreCheck pilot program to strengthen U.S. drug supply chain by improving regulatory predictability.
Enlil, Inc., the unified product lifecycle traceability platform for medical device innovators, today announced the launch of Milestone View, a new capability designed to help MedTech teams replace ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript January 30, 2026 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.44, expectations were ...
Barchart on MSN
2 'strong buy' growth stocks with upside of around 200%
Growth stocks, especially in the biotech sector, often have the potential to deliver outsized returns. A breakthrough in ...
Detailed price information for Lir Life Sciences Corp. (SKNY-CN) from The Globe and Mail including charting and trades.
The State Oil Fund of the Republic of Azerbaijan has signed long-term strategic partnerships with Brookfield Asset Management ...
Amazon announced Tuesday that its Prime members in the US received 8 billion items on the same day or next day last year, up ...
BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...
"Our findings suggest that supraphysiological levels of GIP do not protect against hypoglycaemia in T1 diabetes, consistent with the similar glucagon levels observed during GIP, the GIPR [GIP receptor ...
In early 2025, around 4.9 million British adults - almost one in ten - are estimated to have recently used, or expressed interest in using, glucagon-like peptide-1 (GLP-1) or dual ...
MANILA – The Department of Labor and Employment's PHP61-billion budget for 2026, 19.47 percent higher than last year's budget, will help strengthen its flagship programs. In a statement, the ...
NEW YORK--(BUSINESS WIRE)--Global Infrastructure Partners (“GIP”), a leading infrastructure investor, announced today that the GIP Australia Fund II (“GIPA II” or “the Fund”) has completed fundraising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results